Novel vascular roles of human endoglin in pathophysiology
Journal of Thrombosis and Haemostasis · 2023
DOI: 10.1016/j.jtha.2023.06.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Elisa Rossi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM U1140, Innovative Therapies in Haemostasis, Paris, France. Electronic address: elisa.rossi@parisdescartes.fr. Hauptthemen laut MEDLINE: Endoglin. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Consejo Superior de Investigaciones Científicas, Institut National de la Santé et de la Recherche Médicale.
Abstract (Originalsprache)
Endoglin, alias CD105, is a human membrane glycoprotein highly expressed in vascular endothelial cells. It is involved in angiogenesis and angiogenesis-related diseases, including the rare vascular pathology known as hereditary hemorrhagic telangiectasia type 1. Although endoglin acts as an accessory receptor for members of the transforming growth factor-β family, in recent years, emerging evidence has shown a novel functional role for this protein beyond the transforming growth factor-β system. In fact, endoglin has been found to be an integrin counterreceptor involved in endothelial cell adhesion processes during pathological inflammatory conditions and primary hemostasis. Furthermore, a circulating form of endoglin, also named as soluble endoglin, whose levels are abnormally increased in different pathological conditions, such as preeclampsia, seems to act as an antagonist of membrane-bound endoglin and as a competitor of the fibrinogen-integrin interaction in platelet-dependent thrombus formation. These studies suggest that membrane-bound endoglin and circulating endoglin are important components involved in vascular homeostasis and hemostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, INSERM U1140, Innovative Therapies in Haemostasis, Paris, France. Electronic address: elisa.rossi@parisdescartes.fr.
- Centro de Investigaciones Biológicas Margarita Salas, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Förderung
- Consejo Superior de Investigaciones Científicas
- Institut National de la Santé et de la Recherche Médicale
Zitieren
APA
Rossi, E., & Bernabeu, C. (2023). Novel vascular roles of human endoglin in pathophysiology. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.06.007
Vancouver
Rossi E, Bernabeu C. Novel vascular roles of human endoglin in pathophysiology. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.06.007
BibTeX
@article{Rossi2023,
author = {Rossi, Elisa and Bernabeu, Carmelo},
title = {Novel vascular roles of human endoglin in pathophysiology},
journal = {Journal of Thrombosis and Haemostasis},
year = {2023},
doi = {10.1016/j.jtha.2023.06.007}
}
EUVIMED